Phase 2 Chronic Low Back Pain Study

Completed · Phase 2 · Has a placebo group

Conditions studied: Chronic Low Back Pain

In brief

The primary purpose of this study was to evaluate the analgesic effect and safety of hydrocodone/acetaminophen extended release compared to placebo.

Key facts

Study ID
NCT01364922
Run by
AbbVie (prior sponsor, Abbott)
People needed
168
Starts
2011-06-01
Expected to finish
2011-10-01
Last updated by the study team
2014-01-29

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.